Secukinumab vs Methotrexate
National NHS prescribing compared (Prescription Cost Analysis)
Methotrexate was dispensed 187,649.0× as often as Secukinumab in April 2026 — 187,649 items versus 1 in England.
1items
Secukinumab · April 2026
NHSBSA Prescription Cost Analysis
187,649items
Methotrexate · April 2026
NHSBSA Prescription Cost Analysis
Figure 1. Secukinumab versus Methotrexate: national items dispensed by month
▬ Secukinumab · ╌ Methotrexate
Source: NHSBSA Prescription Cost Analysis, to April 2026
| Measure | Secukinumab | Methotrexate |
|---|---|---|
| Items, April 2026 | 1 | 187,649 |
| Items, last 12 months | 16 | 2,242,345 |
| Net ingredient cost, April 2026 | £609 | £2,311,461 |
See the full profile for Secukinumab or Methotrexate.